{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T21:29:44Z","timestamp":1793568584733,"version":"4.5.0"},"reference-count":68,"publisher":"Oxford University Press (OUP)","issue":"1054","license":[{"start":{"date-parts":[[2013,4,17]],"date-time":"2013-04-17T00:00:00Z","timestamp":1366156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Proximal myopathy presents as symmetrical weakness of proximal upper and\/or lower limbs. There is a broad range of underlying causes including drugs, alcohol, thyroid disease, osteomalacia, idiopathic inflammatory myopathies (IIM), hereditary myopathies, malignancy, infections and sarcoidosis. Clinical assessment should aim to distinguish proximal myopathy from other conditions that can present similarly, identify patients who need prompt attention, like those with cardiac, respiratory or pharyngeal muscle involvement, and determine underlying cause of myopathy. Initial evaluation should include simple tests, like creatine kinase, thyroid function and (25)OH vitamin D levels, but further evaluation including neurophysiological studies, muscle imaging and muscle biopsy should be considered for patients in whom no toxic, metabolic or endocrine cause is found, and in those with clinical features suggestive of inflammatory or hereditary myopathy. Additionally, screening for malignancy and testing for anti-Jo1 antibody is indicated for selected patients with IIM. Management depends on underlying cause, and includes measures, such as removal of offending agent, correction of endocrine or metabolic problem, corticosteroids and immunosuppressive therapy for IIM, and physical therapy, rehabilitation and genetic counselling for muscular dystrophies.<\/jats:p>","DOI":"10.1136\/postgradmedj-2013-131752","type":"journal-article","created":{"date-parts":[[2013,4,17]],"date-time":"2013-04-17T22:23:40Z","timestamp":1366237420000},"page":"470-477","source":"Crossref","is-referenced-by-count":30,"title":["Proximal myopathy: diagnostic approach and initial management"],"prefix":"10.1093","volume":"89","author":[{"given":"Ernest","family":"Suresh","sequence":"first","affiliation":[{"name":"Department of Medicine, Alexandra Hospital , Singapore, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Wimalaratna","sequence":"additional","affiliation":[{"name":"Department of Neurology, Oxford University Hospital, John Radcliffe Hospital , Headington, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,4,17]]},"reference":[{"issue":"6","key":"2023041906233971700_bib1","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3949\/ccjm.68.6.505","article-title":"Inflammatory myopathies: narrowing the differential diagnosis","volume":"68","author":"Rendt","year":"2001","journal-title":"Cleve Clin J Med"},{"key":"2023041906233971700_bib2","volume-title":"Clinical neurology: from the classroom to the exam room","author":"Clark","year":"2007","edition":"1st edn."},{"key":"2023041906233971700_bib3","first-page":"255","article-title":"Practical approach to management of respiratory complications in neurological disorders","volume":"5","author":"Mangera","year":"2012","journal-title":"Int J Gen Med"},{"key":"2023041906233971700_bib4","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1297-319X(03)00012-5","article-title":"Anti-synthetase syndrome","volume":"70","author":"Imbert-Masseau","year":"2003","journal-title":"Joint Bone Spine"},{"key":"2023041906233971700_bib5","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/1757-1626-1-256","article-title":"Hypokalemic periodic paralysis: a case report and review of the literature","volume":"1","author":"Soule","year":"2008","journal-title":"Cases J"},{"key":"2023041906233971700_bib6","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1136\/jnnp.2008.168294","article-title":"Toxic and drug-induced myopathies","volume":"80","author":"Dalakas","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2023041906233971700_bib7","first-page":"158","article-title":"Steroid myopathy: clinical, histologic and cytologic observations","volume":"123","author":"Afifi","year":"1968","journal-title":"Johns Hopkins Med J"},{"key":"2023041906233971700_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/mus.880090102","article-title":"A morphological\/biochemical study on the actions of corticosteroids on rat skeletal muscle","volume":"9","author":"Kelly","year":"1986","journal-title":"Muscle Nerve"},{"key":"2023041906233971700_bib9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jbspin.2010.02.025","article-title":"Glucocorticoid-induced myopathy","volume":"78","author":"Pereira","year":"2011","journal-title":"Joint Bone Spine"},{"key":"2023041906233971700_bib10","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.clinthera.2007.08.022","article-title":"Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and non-diabetic patients","volume":"29","author":"Nichols","year":"2007","journal-title":"Clin Ther"},{"key":"2023041906233971700_bib11","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10557-005-5686-z","article-title":"Mild to moderate muscular symptoms with high dose statin therapy in hyperlipidemic patients- the PRIMO study","volume":"19","author":"Bruckert","year":"2005","journal-title":"Cardiovasc Drugs Ther"},{"key":"2023041906233971700_bib12","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3949\/ccjm.78a.10073","article-title":"Statin myopathy: a common dilemma not reflected in clinical trials","volume":"78","author":"Fernandez","year":"2011","journal-title":"Cleve Clin J Med"},{"key":"2023041906233971700_bib13","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/00001648-200109000-00017","article-title":"Lipid lowering drugs and myopathy: a population-based follow-up study","volume":"12","author":"Gaist","year":"2001","journal-title":"Epidemiology"},{"key":"2023041906233971700_bib14","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1503\/cmaj.070675","article-title":"The efficacy and safety of intensive statin therapy: a meta-analysis of randomized trials","volume":"178","author":"Josan","year":"2008","journal-title":"CMAJ"},{"key":"2023041906233971700_bib15","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1161\/CIRCULATIONAHA.106.624890","article-title":"Risks associated with statin therapy: a systematic overview of randomised clinical trials","volume":"114","author":"Kashani","year":"2006","journal-title":"Circulation"},{"key":"2023041906233971700_bib16","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.clinthera.2006.01.005","article-title":"Statin-related adverse events: a meta-analysis","volume":"28","author":"Silva","year":"2006","journal-title":"Clin Ther"},{"key":"2023041906233971700_bib17","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.clinthera.2007.02.008","article-title":"Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy","volume":"29","author":"Silva","year":"2007","journal-title":"Clin Ther"},{"key":"2023041906233971700_bib18","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/jama.289.13.1681","article-title":"Statin-associated myopathy","volume":"289","author":"Thompson","year":"2003","journal-title":"JAMA"},{"key":"2023041906233971700_bib19","first-page":"233","article-title":"Alcoholic skeletal myopathy: a clinical and pathological study","volume":"55","author":"Martin","year":"1985","journal-title":"Q J Med"},{"key":"2023041906233971700_bib20","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJM198902163200701","article-title":"The effects of alcoholism on skeletal and cardiac muscle","volume":"320","author":"Urbano-Marquez","year":"1989","journal-title":"N Engl J Med"},{"key":"2023041906233971700_bib21","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1097\/01.SMJ.0000100117.79718.DC","article-title":"Chinese red rice-induced myopathy","volume":"96","author":"Smith","year":"2003","journal-title":"South Med J"},{"key":"2023041906233971700_bib22","doi-asserted-by":"crossref","first-page":"474","DOI":"10.7326\/0003-4819-145-6-200609190-00021","article-title":"Symptomatic myopathy due to red yeast rice","volume":"145","author":"Mueller","year":"2006","journal-title":"Ann Intern Med"},{"key":"2023041906233971700_bib23","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1136\/ard.27.6.590","article-title":"Myopathy of hypothyroidism","volume":"27","author":"Fessel","year":"1968","journal-title":"Ann Rheum Dis"},{"key":"2023041906233971700_bib24","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/jnnp.68.6.750","article-title":"Neuromuscular findings in thyroid dysfunction: a prospective clinical and electrodiagnostic study","volume":"68","author":"Duyff","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2023041906233971700_bib25","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1089\/thy.1998.8.1033","article-title":"Myopathy as the persistently isolated symptomatology of primary autoimmune hypothyroidism","volume":"8","author":"Rodolico","year":"1998","journal-title":"Thyroid"},{"key":"2023041906233971700_bib26","first-page":"569","article-title":"Myopathy presenting as a sole manifestation of hypothyroidism","volume":"58","author":"Madhu","year":"2010","journal-title":"J Assoc Physicians India"},{"key":"2023041906233971700_bib27","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1600-0404.1975.tb01358.x","article-title":"Myopathy and neuropathy associated with osteomalacia","volume":"51","author":"Skaria","year":"1975","journal-title":"Acta Neurol Scand"},{"key":"2023041906233971700_bib28","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0140-6736(76)90428-1","article-title":"Muscle weakness in osteomalacia","volume":"1","author":"Schott","year":"1976","journal-title":"Lancet"},{"key":"2023041906233971700_bib29","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1136\/jnnp.39.7.686","article-title":"Electromyography in nutritional osteomalacic myopathy","volume":"39","author":"Irani","year":"1976","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2023041906233971700_bib30","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0889-857X(02)00021-2","article-title":"Idiopathic inflammatory myopathies: epidemiology, classification and diagnostic criteria","volume":"28","author":"Mastaglia","year":"2002","journal-title":"Rheum Dis Clin North Am"},{"key":"2023041906233971700_bib31","first-page":"2230","article-title":"Polymyositis and dermatomyositis: short term and long term outcome, and predictive factors of prognosis","volume":"28","author":"Marie","year":"2001","journal-title":"J Rheumatol"},{"key":"2023041906233971700_bib32","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","article-title":"Polymyositis and dermatomyositis","volume":"362","author":"Dalakas","year":"2003","journal-title":"Lancet"},{"key":"2023041906233971700_bib33","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/ageing\/afj014","article-title":"Inclusion body myositis: an underdiagnosed myopathy of older people","volume":"35","author":"Munshi","year":"2006","journal-title":"Age Ageing"},{"key":"2023041906233971700_bib34","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0140-6736(00)03540-6","article-title":"Frequency of specific cancer types in polymyositis and dermatomyositis: a population based study","volume":"357","author":"Hill","year":"2001","journal-title":"Lancet"},{"key":"2023041906233971700_bib35","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.7326\/0003-4819-134-12-200106190-00008","article-title":"Incidence of malignant disease in biopsy-proven inflammatory myopathy: a population based cohort study","volume":"134","author":"Buchbinder","year":"2001","journal-title":"Ann Intern Med"},{"key":"2023041906233971700_bib36","doi-asserted-by":"crossref","first-page":"843","DOI":"10.47102\/annals-acadmedsg.V39N11p843","article-title":"An 11-year review of Asian patients with dermatomyositis","volume":"39","author":"Liu","year":"2010","journal-title":"Ann Acad Med Singapore"},{"key":"2023041906233971700_bib37","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(02)07815-7","article-title":"Muscular dystrophies","volume":"359","author":"Emery","year":"2002","journal-title":"Lancet"},{"issue":"Part 11","key":"2023041906233971700_bib38","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1093\/brain\/awp236","article-title":"Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population","volume":"132","author":"Norwood","year":"2009","journal-title":"Brain"},{"key":"2023041906233971700_bib39","doi-asserted-by":"crossref","first-page":"340849","DOI":"10.1155\/2010\/340849","article-title":"Inborn errors of energy metabolism associated with myopathies","volume":"2010","author":"Das","year":"2010","journal-title":"J Biomed Biotechnol"},{"key":"2023041906233971700_bib40","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1128\/CMR.00001-08","article-title":"Bacterial, fungal, parasitic and viral myositis","volume":"21","author":"Crum-Cianflone","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"2023041906233971700_bib41","first-page":"98","article-title":"Muscle involvement in sarcoidosis: a retrospective and follow-up studies","volume":"33","author":"Fayad","year":"2006","journal-title":"J Rheumatol"},{"key":"2023041906233971700_bib42","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00005792-197707000-00001","article-title":"A computer assisted analysis of 153 patients with polymyositis and dermatomyositis","volume":"56","author":"Bohan","year":"1977","journal-title":"Medicine"},{"key":"2023041906233971700_bib43","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1212\/WNL.47.1.119","article-title":"Sustained myoglobinuria: the presenting manifestation of dermatomyositis","volume":"47","author":"Rose","year":"1996","journal-title":"Neurology"},{"key":"2023041906233971700_bib44","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.ncl.2011.12.007","article-title":"Electrodiagnostic approach to the patient with suspected myopathy","volume":"30","author":"Lacomis","year":"2012","journal-title":"Neurol Clin"},{"key":"2023041906233971700_bib45","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.rdc.2011.01.007","article-title":"Imaging of skeletal muscle","volume":"37","author":"Goodwin","year":"2011","journal-title":"Rheum Dis Clin North Am"},{"key":"2023041906233971700_bib46","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/archderm.138.7.885","article-title":"Routine versus extensive malignancy search for adult dermatomyositis and polymyositis: a study of 40 patients","volume":"138","author":"Sparsa","year":"2002","journal-title":"Arch Dermatol"},{"key":"2023041906233971700_bib47","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1136\/ard.57.4.198","article-title":"Dermatomyositis- how far to go!","volume":"57","author":"Till","year":"1998","journal-title":"Ann Rheum Dis"},{"key":"2023041906233971700_bib48","doi-asserted-by":"crossref","first-page":"858","DOI":"10.7326\/0003-4819-150-12-200906160-00009","article-title":"Narrative review: statin-related myopathy","volume":"150","author":"Joy","year":"2009","journal-title":"Ann Intern Med"},{"key":"2023041906233971700_bib49","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.amjmed.2009.11.012","article-title":"Conventional cancer screening versus PET\/CT in dermatomyositis\/polymyositis","volume":"123","author":"Selva-O'Callaghan","year":"2010","journal-title":"Am J Med"},{"key":"2023041906233971700_bib50","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/BOR.0b013e3283585731","article-title":"Update: biomarkers for idiopathic inflammatory myopathies","volume":"24","author":"Nasr","year":"2012","journal-title":"Curr Opin Rheumatol"},{"issue":"Part 11","key":"2023041906233971700_bib51","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1113\/jphysiol.2009.186627","article-title":"Muscle channelopathies: does the predicted channel gating pore offer new treatment insights for hypokalemic periodic paralysis?","volume":"588","author":"Matthews","year":"2010","journal-title":"J Physiol"},{"key":"2023041906233971700_bib52","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1161\/01.CIR.0000032466.44170.44","article-title":"ACC\/AHA\/NHLBI Clinical advisory on the use and safety of statins","volume":"106","author":"Pasternak","year":"2002","journal-title":"Circulation"},{"key":"2023041906233971700_bib53","doi-asserted-by":"crossref","first-page":"89C","DOI":"10.1016\/j.amjcard.2006.02.030","article-title":"National Lipid Association Safety Assessment Task Force. Final conclusions and recommendations of the National Lipid Association Safety Assessment Task Force","volume":"97","author":"McKenney","year":"2006","journal-title":"Am J Cardiol"},{"key":"2023041906233971700_bib54","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1001\/archinte.163.6.688","article-title":"Screening for statin-related toxicity: the yield of transaminase and creatine kinase measurements in a primary care setting","volume":"163","author":"Smith","year":"2003","journal-title":"Arch Intern Med"},{"key":"2023041906233971700_bib55","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1001\/archinte.165.22.2671","article-title":"Outcomes in 45 patients with statin-associated myopathy","volume":"165","author":"Hansen","year":"2005","journal-title":"Arch Intern Med"},{"key":"2023041906233971700_bib56","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.amjcard.2006.12.063","article-title":"Effect of coenzyme q10 on myopathic symptoms in patients treated with statins","volume":"99","author":"Caso","year":"2007","journal-title":"Am J Cardiol"},{"key":"2023041906233971700_bib57","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/j.1552-4604.1993.tb03948.x","article-title":"Evidence of plasma CoQ10-lowering effect by HMG-CoA reductase inhibitors: a double-blind placebo controlled study","volume":"33","author":"Ghirlanda","year":"1993","journal-title":"J Clin Pharmacol"},{"key":"2023041906233971700_bib58","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1136\/pgmj.2005.038455","article-title":"Treatment of inflammatory myopathies","volume":"82","author":"Cordeiro","year":"2006","journal-title":"Postgrad Med J"},{"key":"2023041906233971700_bib59","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1055\/s-2008-1062267","article-title":"Inflammatory myopathies: evaluation and management","volume":"28","author":"Greenberg","year":"2008","journal-title":"Semin Neurol"},{"key":"2023041906233971700_bib60","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJM199312303292704","article-title":"A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis","volume":"329","author":"Dalakas","year":"1993","journal-title":"N Engl J Med"},{"key":"2023041906233971700_bib61","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s10067-012-1940-5","article-title":"Intravenous immunoglobulin therapy in adult patients with polymyositis\/dermatomyositis: a systematic literature review","volume":"31","author":"Wang","year":"2012","journal-title":"Clin Rheumatol"},{"key":"2023041906233971700_bib62","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1056\/NEJM199205213262102","article-title":"Controlled trial of plasma exchange and leukapheresis in polymyositis and dermatomyositis","volume":"326","author":"Miller","year":"1992","journal-title":"N Engl J Med"},{"key":"2023041906233971700_bib63","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/art.20849","article-title":"Rituximab in the treatment of dermatomyositis: an open-label pilot study","volume":"52","author":"Levine","year":"2005","journal-title":"Arthritis Rheum"},{"key":"2023041906233971700_bib64","first-page":"1021","article-title":"Rituximab as therapy for refractory polymyositis and dermatomyositis","volume":"33","author":"Noss","year":"2006","journal-title":"J Rheumatol"},{"key":"2023041906233971700_bib65","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1001\/archderm.143.6.763","article-title":"A pilot trial of rituximab in the treatment of patients with dermatomyositis","volume":"143","author":"Chung","year":"2007","journal-title":"Arch Dermatol"},{"key":"2023041906233971700_bib66","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1093\/rheumatology\/ker292","article-title":"Safety and exercise training in patients with an idiopathic inflammatory myopathy: a systematic review","volume":"50","author":"Habers","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"2023041906233971700_bib67","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1474-4422(09)70272-8","article-title":"Diagnosis and management of Duchenne muscular dystrophy. Part 2: implementation of multidisciplinary care","volume":"9","author":"Bushby","year":"2010","journal-title":"Lancet Neurol"},{"key":"2023041906233971700_bib68","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1056\/NEJM198906153202405","article-title":"Randomised double-blind six month trial of prednisolone in Duchenne's muscular dystrophy","volume":"320","author":"Mendell","year":"1989","journal-title":"N Engl J Med"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/89\/1054\/470\/50017643\/postgradmedj-89-470.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/89\/1054\/470\/50017643\/postgradmedj-89-470.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T02:35:22Z","timestamp":1681871722000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/89\/1054\/470\/6987501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,17]]},"references-count":68,"journal-issue":{"issue":"1054","published-online":{"date-parts":[[2013,4,17]]},"published-print":{"date-parts":[[2013,8,1]]}},"URL":"https:\/\/doi.org\/10.1136\/postgradmedj-2013-131752","relation":{},"ISSN":["0032-5473","1469-0756"],"issn-type":[{"value":"0032-5473","type":"print"},{"value":"1469-0756","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2013,8]]},"published":{"date-parts":[[2013,4,17]]}}}